Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 3 × Withdrawn × 90 days × Clear all

Phase

Phase NA 23 Phase 2 15 Phase 1/2 10 Phase 1 8 Phase EARLY_PHASE1 3 Phase 3 2 Phase 4 1

Status

Recruiting 439 Active not recruiting 335 Completed 121 Not yet recruiting 97 Terminated 15 Enrolling by invitation 8 Suspended 6 Withdrawn 2

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1 Breast 1

Conditions

Urologic Neoplasms 1 Neoplasms 1 Breast Neoplasms 1

Interventions

trastuzumab deruxtecan 1 ribociclib 1 abemaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07342517 2026-03-17

RESCUE

Relmada Therapeutics, Inc.

Phase 3 Withdrawn

Neoplasms, Urologic Neoplasms

NCT06585969 2026-02-12

DISCORDANT

Danish Breast Cancer Cooperative Group

Phase 3 Withdrawn

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡